Limit Confusion and Other Issues With Paxlovid
July 2022
You can help prevent problems when patients taking nirmatrelvir/ritonavir (Paxlovid) for COVID-19 are admitted.
High-risk OUTpatients with a positive COVID-19 test should start this antiviral combo within 5 days of symptom onset.
And if a patient is hospitalized before the course is complete, clinicians may want to finish it.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote